Dravet syndrome is a rare, lifelong genetic epilepsy that begins in the first year of life, often in otherwise healthy infants. Seizures typically start with prolonged febrile or temperature‑triggered events and evolve into multiple seizure types that can be frequent and hard to control; many children also develop developmental delays, movement or balance challenges, and features like sensitivity to heat or flashing lights. Not everyone will have the same experience, but seizures often persist into adulthood and the condition can bring risks such as status epilepticus and, rarely, sudden unexpected death in epilepsy (SUDEP). Treatment focuses on reducing seizures and improving quality of life using a tailored combination of anti‑seizure medicines (avoiding those that can worsen seizures), prescription cannabidiol, stiripentol with clobazam and valproate, fenfluramine, rescue medicines for long seizures, and sometimes ketogenic diet or devices like vagus nerve stimulation. Regular follow‑up with a neurologist, seizure safety planning, and supportive therapies such as physical, occupational, and speech therapy are key for many living with Dravet syndrome.
Overview
Dravet syndromeSymptoms
Early symptoms of Dravet syndrome include long, hard‑to‑stop seizures beginning in the first year, often with fever. Over time, multiple seizure types appear, triggered by temperature or flashing lights. Many also develop developmental slowing, speech and balance difficulties.
Outlook and prognosis
Many living with Dravet syndrome grow and learn, but seizures often remain frequent and can be triggered by fever or heat. Developmental progress varies; some need full-time support while others gain partial independence. Early, consistent care lowers complications and sudden death risk.
Causes and risk factors
Most cases stem from a new SCN1A gene change; fewer are inherited. Risk increases with a parental SCN1A variant or family epilepsy history. Fever, illness, heat, flashing lights, and some medicines can trigger or worsen symptoms.
Genetic influences
Genetics is central in Dravet syndrome. Most people have a change in the SCN1A gene, which disrupts brain signaling and drives seizures and developmental challenges. Genetic testing helps confirm Dravet syndrome, guide treatment choices, and support family planning.
Diagnosis
Doctors suspect Dravet syndrome from early seizure patterns and developmental history. Diagnosis of Dravet syndrome is supported by EEG and excluded other causes, then confirmed with genetic tests. Early genetic diagnosis of Dravet syndrome guides care.
Treatment and drugs
Treatment for Dravet syndrome focuses on reducing seizures, protecting development, and supporting day-to-day life. Care often combines anti‑seizure medicines tailored to Dravet, rescue therapies for prolonged seizures, ketogenic diet, cautious fever management, and emerging options like preventive injections. Regular therapies—physical, occupational, speech—and coordinated neurology follow‑up help families navigate learning, sleep, and safety.
Symptoms
Families often first notice long seizures linked to fevers in an otherwise healthy infant, followed by new seizure types and delays in skills. Features vary from person to person and can change over time. Common early features of Dravet syndrome include prolonged febrile seizures, sensitivity to temperature changes, and later challenges with development, movement, and speech.
Long seizures during a fever (38°C/100.4°F or higher) often appear in the first year of life. They may involve the whole body or just one side. These early events are a hallmark many families see with Dravet syndrome.
Seizures often last longer than 5 minutes and can cluster. Very long events are emergencies and may need rescue medicine per your care plan.
Over time, different kinds of seizures can occur, including stiffening, jerks, brief staring, or sudden drops. This variety is common in Dravet syndrome and can make patterns hard to predict.
Sudden temperature changes, warm baths, or overheating can trigger seizures. Even a mild fever can raise risk on a given day.
How people usually first notice Dravet syndrome?
Families often first notice Dravet syndrome in a baby who has a long seizure with fever—often a generalized convulsion—starting in the first year of life, typically around 5 to 8 months. After that first event, seizures may recur with even mild fevers or warm baths, and different seizure types can appear, prompting urgent evaluation. Parents and clinicians may also see that development, which was on track at first, begins to slow or plateau after these early seizures—these patterns are common “first signs of Dravet syndrome” and guide how Dravet syndrome is first noticed.
Types of Dravet syndrome
Dravet syndrome has a few recognized clinical variants, mostly defined by the gene involved and how early and severely seizures begin. These variants can look similar day to day, with prolonged seizures in infancy followed by developmental challenges, but the pace and mix of symptoms can differ. Clinicians often describe them in these categories: classic Dravet syndrome, Dravet-like epilepsies due to other genes, and milder SCN1A-related forms. Not everyone will experience every type.
Classic Dravet syndrome
Symptoms start in the first year with long seizures, often triggered by fever or warm baths. Over time, multiple seizure types and developmental slowing emerge. Gait and speech can be affected as childhood progresses.
SCN1A-related spectrum
Changes in the SCN1A gene can range from classic Dravet to milder epilepsy with fever-sensitive seizures. Early symptoms of Dravet syndrome within this spectrum often include prolonged febrile seizures in infancy. Learning and behavior impacts vary from mild to more pronounced.
Non-SCN1A Dravet-like
Similar features may occur with changes in genes such as PCDH19, GABRA1, STXBP1, or SCN2A. Seizure patterns can mimic Dravet syndrome but development and triggers may differ. Genetic testing helps clarify the variant and guide care.
GEFS+ milder end
Some families show a milder, related pattern called genetic epilepsy with febrile seizures plus. Seizures often start with fever in childhood and may persist beyond age 6, but development is usually less affected. This sits on the broader SCN1A-related spectrum of types of Dravet syndrome.
What genetics can tell you about symptoms
Most people with Dravet syndrome have changes in the SCN1A gene, which disrupts a sodium channel in brain cells and leads to prolonged febrile seizures, later frequent seizures, and developmental slowing. Certain variants tend to worsen heat and light sensitivity and trigger-status risk.
Causes and risk factors
Most cases of Dravet syndrome are caused by a new (not inherited) change in the SCN1A gene that alters how brain cells handle electrical signals. Less often, the genetic causes of Dravet syndrome involve other genes (including PCDH19, more often in females) or an SCN1A change passed down from a parent. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Fevers, warm baths or hot weather, illness, flashing lights, and lack of sleep don’t cause the condition but can trigger seizures or make them more frequent. Family history of epilepsy or a known SCN1A variant raises risk for siblings, while vaccines do not cause Dravet syndrome—though a fever after a shot can act as a trigger.
Environmental and biological risk factors
Families often wonder why Dravet syndrome happens and whether anything in pregnancy or the home made it more likely. Doctors often group risks into internal (biological) and external (environmental). For this condition, most risk rests in biology that forms before birth, while everyday exposures play a much smaller role. Knowing the difference can help you focus on what’s controllable before any early symptoms of Dravet syndrome appear.
Having a father in his mid-to-late 40s or older at the time of conception slightly raises the chance of new changes arising in the child. This modestly increases the likelihood of conditions like Dravet syndrome that begin early in life.
Conception at an older maternal age may very slightly increase the chance of new changes forming before or at fertilization. The effect seems smaller than paternal age and, for most families, the absolute risk remains low.
Substantial ionizing radiation exposure to a parent before conception can increase new changes in eggs or sperm. Such exposure is uncommon outside medical radiation therapy or serious accidents.
Typical exposures during pregnancy, such as routine air pollution or household chemicals, have not been shown to increase risk for this condition. Research continues, but no specific prenatal exposure has a confirmed link.
Genetic risk factors
In most children with Dravet syndrome, the underlying cause is a new change in a gene that helps brain cells control electrical signals. The SCN1A gene is the main gene involved; when it doesn’t work as expected, seizures often begin in the first year of life. Some risk factors are inherited through our genes. Because early symptoms of Dravet syndrome often start in infancy, genetic testing can clarify the cause and guide treatment.
SCN1A variants: Most people with Dravet syndrome have a change in the SCN1A gene, which helps brain cells control electrical signals. When this gene is altered, brain networks become easier to trigger, leading to seizures and developmental effects.
De novo changes: In most families, the SCN1A change is new in the child and not present in either parent. This usually means parents did nothing to cause it, and the chance of it happening again is low but not zero.
Inherited SCN1A changes: Less often, a parent carries the SCN1A change and may have had mild febrile seizures or none at all. In these families, the chance of Dravet syndrome or related epilepsy can be higher for future children.
Parental mosaicism: Sometimes a parent carries the change in only some egg or sperm cells, so standard blood tests look normal. This hidden mosaic pattern can increase the chance of having another child with Dravet syndrome.
SCN1A copy changes: Small missing or extra pieces of DNA that include SCN1A or nearby genes can cause Dravet syndrome. These changes usually require tests that look for copy-number differences, not just single-letter changes.
Related gene changes: Rare changes in other sodium channel or GABA-signaling genes can produce a Dravet-like pattern or overlap with Dravet syndrome. Naming the exact gene can help tailor care and inform family planning.
Modifier variants: Additional gene changes that do not cause Dravet syndrome on their own may influence when seizures start and how intense they are. This helps explain why severity varies between people with the same main SCN1A change.
Variant type matters: The exact spot and type of SCN1A change can shape seizures and development. Changes that stop the gene early often link with more typical Dravet features, while some single-letter swaps can have more mixed effects.
Lifestyle risk factors
Daily habits don’t cause Dravet syndrome, but they can nudge seizures closer or farther away. Genetics sets a backdrop, but daily choices paint the scene. Below are common lifestyle risk factors for Dravet syndrome and how to lower their impact in day-to-day life. If you’re wondering how lifestyle affects Dravet syndrome, these are the areas families often focus on together.
Short or broken sleep can make seizures more likely the next day. A steady bedtime and wake time often helps stabilize the brain’s rhythm.
Hot baths, saunas, or heavy clothing in warm weather can raise body temperature and trigger seizures. Choose lukewarm baths, light layers, and cool spaces during heat.
All-out, high-heat workouts may lead to overheating or exhaustion that lowers the seizure threshold. Gentle to moderate activity with breaks is usually safer and can support overall health.
Not drinking enough can raise body temperature and stress the body, especially during illness or activity. Offer regular fluids, and consider electrolytes if there’s heavy sweating.
Risk prevention
Dravet syndrome itself can’t be prevented, but you can lower risks tied to seizures and complications. Prevention works best when combined with regular check-ups. Knowing your risks can guide which preventive steps matter most. Spotting early symptoms of Dravet syndrome—like long seizures with fever in the first year of life—can help start treatment sooner and reduce emergencies.
Treat fever quickly with acetaminophen or ibuprofen as advised. Cooling measures and fluids can help keep temperature down. Seek urgent care for seizures lasting longer than 5 minutes or repeated seizures.
Avoid overheating from hot baths, saunas, or intense heat; heat can trigger seizures. Dress in breathable layers and keep rooms comfortably cool. Watch for fever above 38°C (100.4°F).
Keep routine vaccines up to date to lower the chance of infections that cause fever. Good handwashing, timely flu shots, and prompt care for illness can reduce seizure clusters.
Regular, adequate sleep helps make seizures less likely. Keep consistent bed and wake times, including weekends. Address snoring or sleep disruption with the care team.
Transmission
Dravet syndrome is not contagious and cannot be caught or spread between people. It happens because of a change in a gene involved in brain signaling, and in most children this change arises for the first time in them rather than being passed down from a parent.
When Dravet syndrome is inherited, a single changed copy of the gene can be enough to cause it, so a parent who carries the gene change—even if they have mild or no symptoms—has a 50% chance with each pregnancy to pass it on. Even when both parents have normal testing, there is still a small chance of having another child with Dravet syndrome because a parent may carry the change in a small number of egg or sperm cells. A genetics visit can help clarify how Dravet syndrome is inherited and discuss the genetic transmission of Dravet syndrome for your family.
When to test your genes
Dravet syndrome is a genetic epilepsy; testing is appropriate at first signs of prolonged febrile seizures in infancy, epilepsy that resists multiple medicines, or seizures plus developmental slowing. Genetic confirmation guides medication choices and avoids seizure‑worsening drugs. Test earlier if there’s a family history of SCN1A‑related epilepsy.
Diagnosis
For many families, the first signs are long seizures in the first year of life, sometimes linked to fever, that keep coming back despite early treatment. Doctors usually begin by putting together the seizure timeline, triggers, and development to see if the pattern fits Dravet syndrome. From there, testing helps confirm the cause and rule out other conditions. An early diagnosis of Dravet syndrome can guide safer medication choices and care planning.
Seizures often start between 2 and 12 months, frequently after fever or vaccines, and later include different seizure types. Over time, many children show slowing of skills or coordination. This recognizable pattern raises concern for Dravet syndrome.
Detailed notes about the first prolonged seizure, any repeated status epilepticus, and seizure types provide key clues. Parents’ observations about fever, baths, or warm weather triggering events are especially helpful. This history helps point toward Dravet syndrome.
Many have seizures with fever or fast temperature changes, such as after a hot bath. This temperature sensitivity is common in Dravet syndrome and helps distinguish it from other epilepsies.
Doctors assess development, movement, balance, and speech. Subtle findings may appear after the first year, supporting the clinical picture of Dravet syndrome.
Stages of Dravet syndrome
Many specialists describe three broad phases that people with Dravet syndrome may move through from infancy into adulthood. The pattern varies by child, and not everyone fits neatly into each phase. Early symptoms of Dravet syndrome often include long seizures with fever in the first year of life. Early and accurate diagnosis helps you plan ahead with confidence.
Early infancy
Long seizures linked to fever or warm temperatures start, often in the first year. Development is usually typical at first, though recovery after prolonged seizures can be slow. Seizures may last over 5 minutes and sometimes become emergencies.
Childhood worsening
Different seizure types become frequent and harder to control, and triggers like fever or heat remain important in Dravet syndrome. Learning, language, and motor skills may slow or plateau, and balance or coordination problems can appear. Prolonged seizures can still happen and may require emergency care.
Adolescent stabilization
Convulsive seizures often lessen in number, though epilepsy typically continues in Dravet syndrome. Day-to-day challenges with learning, behavior, and movement usually persist and may need ongoing supports. Sensitivity to heat or illness can continue, so trigger management remains key.
Outlook and prognosis
Even though it can feel overwhelming, many children with Dravet syndrome make meaningful gains in communication, mobility, and learning when seizures are better controlled and safety plans are in place. Seizures usually remain part of life, but their pattern can shift over time. Many families notice very frequent seizures in early childhood, followed by fewer prolonged convulsive seizures in later childhood and adolescence, with ongoing challenges like drop seizures, behavior changes, and sleep issues. Some children develop slowly at first, then plateau; others make small, steady steps. Doctors call this the prognosis—a medical word for likely outcomes.
Looking at the long-term picture can be helpful. Life expectancy in Dravet syndrome is reduced compared with the general population, largely due to status epilepticus (very long seizures), accidents related to seizures, and a higher risk of sudden unexpected death in epilepsy (SUDEP). With vigilant seizure management, rescue plans, and nocturnal safeguards, many people maintain safer routines and reduce emergency visits. Early symptoms of Dravet syndrome often predict care needs later, so tracking triggers, fever responses, and seizure clusters can guide therapy changes.
The outlook is not the same for everyone, but most people with Dravet syndrome will have some degree of lifelong learning and movement differences, and many need support with daily activities into adulthood. Newer treatments—such as targeted antiseizure medicines, dietary therapy, gene-directed options, and neuromodulation—are improving seizure control for some, which can support better developmental progress. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Dravet syndrome often brings ongoing challenges that touch learning, movement, sleep, and safety as people grow. Long-term effects vary widely, and needs can shift from childhood into adulthood. Seizures often remain a part of life, even with treatment, and can influence development over time. While serious risks exist, many living with Dravet syndrome reach adulthood with tailored care and strong support networks.
Seizures often continue from childhood into adulthood and can be hard to fully control. Different types may appear over time, including convulsive and non-convulsive events. This ongoing activity can affect day-to-day learning and energy.
Learning and thinking skills may progress more slowly than peers, with gaps widening over time. Early symptoms of Dravet syndrome, like frequent seizures in the first year of life, can set the stage for later learning challenges. Many benefit from individualized education plans.
Expressive speech may lag, with fewer words or shorter phrases than expected. Understanding language can be stronger than speaking it. Communication devices or therapies may support everyday conversation.
Balance and coordination can be unsteady, and a crouched or wide-based walk may develop. Muscle tone may be low, and fine motor skills can remain difficult. These changes can make stairs, playgrounds, or uneven ground harder to navigate.
How is it to live with Dravet syndrome?
Living with Dravet syndrome often means planning each day around seizure safety, temperature and light triggers, and medication schedules, while staying ready for emergencies. Many families build routines to reduce risks—cooling strategies in hot weather, careful fever management, and avoiding overexertion—yet unpredictability can still interrupt school, work, sleep, and social plans. Over time, developmental and behavioral challenges may affect learning and communication, so therapies, special education supports, and consistent caregiving become part of daily life. People around the child—parents, siblings, teachers, friends—often learn seizure first aid and adapt environments, and while the load can be heavy, community support, coordinated medical care, and respite resources can make a meaningful difference.
Treatment and drugs
Treatment for Dravet syndrome focuses on reducing seizures, protecting development, and supporting day-to-day life. Doctors often use a combination of anti-seizure medicines such as valproate, clobazam, stiripentol, cannabidiol (Epidiolex), fenfluramine (Fintepla), and topiramate; sodium‑channel–blocking drugs like carbamazepine and lamotrigine are usually avoided because they can worsen seizures. If medicines don’t control seizures well, the ketogenic diet, vagus nerve stimulation, or, in select cases, epilepsy surgery may be considered, and your doctor may adjust your dose to balance benefits and side effects. Alongside medical treatment, lifestyle choices play a role, including fever prevention, prompt treatment of infections, and avoiding known seizure triggers like overheating or flashing lights. Supportive care can make a real difference in how you feel day to day, with physical, occupational, and speech therapy, rescue medications for emergencies, and coordinated care with an epilepsy specialist.
Non-drug treatment
Alongside medicines, non-drug therapies can lower seizure risk, support development, and make day-to-day life safer for families living with Dravet syndrome. These approaches focus on fewer seizures, steadier learning and movement, and less stress for caregivers. They work best when tailored to your child’s needs and updated as they grow.
A high‑fat, very low‑carb diet can reduce seizure frequency for some people with Dravet syndrome. It needs medical supervision and dietitian support to keep nutrition balanced. Families often see benefits after several weeks.
A small implanted device sends gentle pulses to a nerve in the neck to help calm seizures. It can lessen seizure intensity and recovery time in Dravet syndrome. The care team adjusts settings over time.
Targeted exercises build strength, balance, and coordination that seizures and low tone can affect. Therapists adapt activities to prevent falls and improve mobility at home and school.
Daily‑living skills like dressing, feeding, and play are broken into manageable steps. Therapists suggest tools and routines that fit your child’s abilities and reduce frustration in Dravet syndrome.
Your genes may have an impact on how drugs work for you
In Dravet syndrome, gene changes—especially in SCN1A—can affect how the brain’s sodium channels respond to certain anti‑seizure medicines. This is why some drugs worsen seizures while others help, guiding doctors toward sodium‑channel–sparing options and individualized dosing.
Pharmacological treatments
Medicines for Dravet syndrome aim to reduce how often and how long seizures last, and to make everyday life safer. First-line medications are those doctors usually try first, based on their track record and safety in Dravet syndrome. Some drugs are added together to boost seizure control, and dosing is adjusted slowly to balance benefits and side effects. Your team will also plan rescue options for long seizures and advise on drugs that may make seizures worse.
Often used early as a daily base medicine to lower convulsive seizures. Regular blood tests track liver health and platelets, and some may notice weight changes or tummy upset. People who may become pregnant should discuss safer alternatives.
A calming medicine that can be taken daily to prevent seizures. Sleepiness and drooling can occur, and behavior changes like irritability may happen in some.
Added to clobazam and usually valproate to strengthen seizure control. It can raise clobazam levels, so doses may be adjusted, and appetite or weight may drop.
Specifically approved for Dravet syndrome to reduce convulsive seizures. It can lower appetite and weight, and regular heart checks (echocardiograms) are required to monitor for rare valve or lung vessel changes.
Genetic influences
For most families, Dravet syndrome starts with a new, random change in a single gene rather than something that clearly runs in the family. The change is most often in a gene called SCN1A, which helps brain cells control the electrical signals that trigger seizures. In many children, this change is not inherited from either parent; less commonly it can be passed from parent to child, and a parent with the gene change may have milder seizures or none at all—yet each child then has a 1 in 2 (50%) chance of inheriting it. Other, rarer genes can also cause Dravet syndrome, including some that affect sodium channels or, in girls, genes on the X chromosome. Because the exact gene and the size of the change vary, the age at first seizure and overall severity can differ widely, even within the same family. DNA testing can sometimes identify these changes, and genetic testing for Dravet syndrome can guide treatment choices, inform family planning, and clarify the chance of the condition happening again—though when the change arises anew, the repeat risk is usually low but not zero because it can rarely be present only in a parent’s eggs or sperm.
Is Dravet syndrome genetic?
Genetics is central in Dravet syndrome. Most people have a change in the SCN1A gene, which disrupts brain signaling and drives seizures and developmental challenges. Genetic testing helps confirm Dravet syndrome, guide treatment choices, and support family planning.
Pharmacogenetics—how genetics influence drug effects
Because most Dravet syndrome is linked to changes in the SCN1A gene, the diagnosis itself often guides which seizure medicines to use and which to avoid. In many, drugs that block sodium channels (such as carbamazepine, oxcarbazepine, lamotrigine, or phenytoin) can make seizures worse, so teams generally steer away from them and instead consider options like valproate, clobazam, stiripentol, cannabidiol, or fenfluramine. Genes can influence how quickly you break down certain seizure medicines, such as clobazam, which may change the dose you need. Differences in the CYP2C19 gene can raise or lower levels of clobazam’s active metabolite, so your clinician may start at a different dose, check levels, or watch closely for sleepiness or behavior changes. If there’s concern about a POLG-related mitochondrial disorder, valproate is usually avoided because of a higher risk of serious liver problems in that setting, and targeted testing may be discussed before starting therapy. Pharmacogenetic testing in Dravet syndrome does not replace careful follow-up, because people with similar results may still respond differently; doctors use genetic findings alongside age, seizure types, and past side effects to tailor treatment.
Interactions with other conditions
Infections like colds or ear infections, even with a mild fever, can trigger more or longer seizures in Dravet syndrome, so everyday bugs often feel bigger than they should. Behavior and learning differences such as autism features, attention difficulties, and sleep problems commonly occur alongside Dravet syndrome—doctors call it a “comorbidity” when two conditions occur together. When another illness brings fever, dehydration, pain, or poor sleep, seizures may become more frequent or harder to control until the other problem settles. Some medicines used for unrelated issues can interact with seizure treatments or lower the seizure threshold; for example, certain antibiotics or antifungals can change levels of anti‑seizure medications, and some over‑the‑counter cold and allergy remedies can be stimulating or sedating in ways that complicate care. Vaccines do not cause Dravet syndrome, but fever after a shot can unmask early symptoms of Dravet syndrome or trigger a seizure; planning with your neurology team around dosing, fever control, and timing helps keep vaccinations on track. Coordinated care among neurology, pediatrics, sleep, and behavioral health can reduce these cross‑effects and keep day‑to‑day life steadier.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described infants who developed normally for a few months and then began having long, fever‑triggered seizures that changed the course of childhood. Families told of a baby who spiked a temperature after routine vaccines or a viral illness and had a prolonged convulsion; months later, different seizure types appeared, and development slowed. Looking back helps explain why these stories were often grouped under broad labels like childhood epilepsy before doctors recognized a distinct pattern.
First described in the medical literature as severe myoclonic epilepsy of infancy in 1978 by French neurologist Charlotte Dravet, the condition was initially defined by its early, long seizures, sensitivity to fever, and later mixed seizure types. Over time, descriptions became clearer: children with Dravet syndrome often had normal early milestones, then developed challenges with speech, movement, and learning as seizures persisted. Clinicians also noted that seizures could be triggered by fast temperature changes, flashing lights, or illness, and that standard epilepsy medicines sometimes worsened seizures rather than helped.
In the late 1990s and early 2000s, advances in genetics showed that many people with Dravet syndrome have a change in a gene called SCN1A, which helps control how brain cells pass electrical signals. This discovery confirmed that Dravet syndrome is not simply “difficult epilepsy,” but a specific brain network disorder with a recognizable cause in most cases. It also explained why certain medicines that block sodium channels can aggravate seizures in this condition, guiding safer treatment choices.
As medical science evolved, the name shifted from severe myoclonic epilepsy of infancy to Dravet syndrome to reflect the broader picture beyond myoclonic seizures alone. Doctors learned that not everyone has the same genetic finding, and that symptoms can vary from child to child, yet the overall pattern—early prolonged seizures, fever sensitivity, and later developmental effects—remains consistent. This helped create clearer diagnostic criteria and encouraged earlier referral for genetic testing.
In recent decades, awareness has grown, and research has expanded treatment options. Specialized diets, rescue medicines for long seizures, and newer antiseizure therapies have improved day‑to‑day management. More recently, targeted approaches, including therapies that aim to boost the function of the affected sodium channel, are being studied. Each stage in history has added to the picture we have today, moving from scattered case reports to a well‑defined diagnosis with tailored care pathways and growing support networks for people living with Dravet syndrome and their families.